These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors. Günther T, Schneider-Stock R, Rys J, Niezabitowski A, Roessner A. J Cancer Res Clin Oncol; 1997; 123(7):388-94. PubMed ID: 9260591 [Abstract] [Full Text] [Related]
25. In microdissected ductal carcinoma in situ, HER-2/neu amplification, but not p53 mutation, is associated with high nuclear grade and comedo histology. Ho GH, Calvano JE, Bisogna M, Borgen PI, Rosen PP, Tan LK, Van Zee KJ. Cancer; 2000 Dec 01; 89(11):2153-60. PubMed ID: 11147584 [Abstract] [Full Text] [Related]
26. Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumors. Plummer SJ, Paris MJ, Myles J, Tubbs R, Crowe J, Casey G. Genes Chromosomes Cancer; 1997 Dec 01; 20(4):354-62. PubMed ID: 9408751 [Abstract] [Full Text] [Related]
27. Mutation at chromosome 11q23 in human non-familial breast cancer: a microdissection microsatellite analysis. Koreth J, Bethwaite PB, McGee JO. J Pathol; 1995 May 01; 176(1):11-8. PubMed ID: 7616353 [Abstract] [Full Text] [Related]
28. Quantitative analysis of chromosome in situ hybridization signal in paraffin-embedded tissue sections. Dhingra K, Sneige N, Pandita TK, Johnston DA, Lee JS, Emami K, Hortobagyi GN, Hittelman WN. Cytometry; 1994 Jun 01; 16(2):100-12. PubMed ID: 7924678 [Abstract] [Full Text] [Related]
29. Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas. Chappell SA, Walsh T, Walker RA, Shaw JA. Br J Cancer; 1997 Jun 01; 75(9):1324-9. PubMed ID: 9155053 [Abstract] [Full Text] [Related]
30. Evaluation of numeric alterations of chromosomes 1 and 17 by in situ hybridization in invasive breast carcinoma with clinicopathologic parameters. Nakopoulou L, Giannopoulou I, Trafalis D, Gakiopoulou H, Keramopoulos A, Davaris P. Appl Immunohistochem Mol Morphol; 2002 Mar 01; 10(1):20-8. PubMed ID: 11893031 [Abstract] [Full Text] [Related]
37. p53 mutation in epithelial ovarian carcinoma and borderline ovarian tumor. Lee JH, Kang YS, Park SY, Kim BG, Lee ED, Lee KH, Park KB, Kavanagh JJ, Wharton JT. Cancer Genet Cytogenet; 1995 Nov 01; 85(1):43-50. PubMed ID: 8536236 [Abstract] [Full Text] [Related]
39. Genomic patterns of allelic imbalance in disease free tissue adjacent to primary breast carcinomas. Ellsworth DL, Ellsworth RE, Love B, Deyarmin B, Lubert SM, Mittal V, Shriver CD. Breast Cancer Res Treat; 2004 Nov 01; 88(2):131-9. PubMed ID: 15564796 [Abstract] [Full Text] [Related]
40. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Jones TD, Eble JN, Wang M, MacLennan GT, Delahunt B, Brunelli M, Martignoni G, Lopez-Beltran A, Bonsib SM, Ulbright TM, Zhang S, Nigro K, Cheng L. Clin Cancer Res; 2005 Oct 15; 11(20):7226-33. PubMed ID: 16243792 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]